PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 54 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218 | -33.5% | 70,583 | -3.1% | 0.02% | -42.4% |
| Q2 2023 | $328 | +21.0% | 72,834 | +53.0% | 0.03% | +22.2% |
| Q1 2023 | $271 | -6.2% | 47,614 | -0.4% | 0.03% | -25.0% |
| Q4 2022 | $289 | -99.9% | 47,801 | -11.8% | 0.04% | -23.4% |
| Q3 2022 | $358,000 | +87.4% | 54,173 | +47.9% | 0.05% | +62.1% |
| Q2 2022 | $191,000 | +19.4% | 36,626 | +57.9% | 0.03% | +38.1% |
| Q1 2022 | $160,000 | – | 23,201 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |